Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?

There are a few case reports of VTE following COVID-19 vaccinations (approximately 10 based on my PubMed review today). However, VTE has a high incidence of 0.1% in the general population and much higher after age 45 (Mary Cushman, PMID 17433897), so determining a causal relationship between the vac...

We have had several instances of severe thrombocytopenia (platelets 1K) following the vaccine. Hard to convince the patient (let alone ourselves) to go for a booster; perhaps administer Evusheld as an alternative?